Dentsply Sirona (WBO:XRAY) ROCE %

: 5.31% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Dentsply Sirona's annualized ROCE % for the quarter that ended in Dec. 2023 was 5.31%.

Dentsply Sirona ROCE % Historical Data

The historical data trend for Dentsply Sirona's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dentsply Sirona Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

4.83

-0.05

7.88

-14.19

-1.49

Dentsply Sirona Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %																1.95	-0.56	4.20	-15.13	5.31

Dentsply Sirona ROCE % Calculation

Dentsply Sirona's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-86.198	/	( ( (7214.992 - 1104.48)	+	(6758.29 - 1306.725) )	/ 2 )
	=	-86.198	/	( (6110.512	+	5451.565)	/ 2 )
	=	-86.198	/	5781.0385
	=	-1.49 %

Dentsply Sirona's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	293.44	/	( ( (6747.337 - 1141.266)	+	(6758.29 - 1306.725) )	/ 2 )
	=	293.44	/	( ( 5606.071	+	5451.565 )	/ 2 )
	=	293.44	/	5528.818
	=	5.31 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Dentsply Sirona (WBO:XRAY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Dentsply Sirona ROCE % Related Terms

Thank you for viewing the detailed overview of Dentsply Sirona's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dentsply Sirona (WBO:XRAY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Dentsply Sirona Inc (WBO:XRAY) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

XRAY:USA DY2:Germany

Address

13320 Ballantyne Corporate Place, Charlotte, NC, USA, 28277-3607

Website

https://www.dentsplysirona.com

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).